cerrar
Tagged with

Interview with Andrew Somers, President & CEO, American…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you…

Interview with Svetlana Zavidova, Executive Director, Association…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment,…

Interview with Cheng-Ho Tsai, Superintendent, Mackay Memoral…
Cheng-Ho Tsai, Mackay Memorial Hospital has a unique background and origins. How has this endured through the different stages of the pharmaceutical…

Interview with Chi-Huey Wong, President, Academia Sinica
Academia Sinica celebrated its 80th anniversary in 2008. After this milestone, how does the institute define its activities today? Academia Sinica…

Interview with Andrew Giddy, CEO, Nucleus Network
Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research…

Interview with Rosa Maria Scavarelli, President, Theraskin Brazil
When we met you in 2007, as the head of the former Igefarma, the company was undergoing a transition – from branded generics into dermocosmetics…

Interview with Rogerio MANSUR, Director of Operations, DHL Life…
Rogerio, you were one of the people responsible for integrating two well-established companies in the Brazilian market with the acquisition of Exel by…

Interview with Mark Brown, Head of Tahiland/Vietnam Cluster,…
You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are…

Interview with Norbert Oppitz, Senior Vice President Latin…
Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this…

Interview with Richard Davies, Managing Director, Amgen Australia
What impact have the PBS reforms had on Amgen in Australia? From a company perspective, biotechnology companies exist in a competitive space. They…

Interview with Will Delaat, Chairman, Pharmaceutical Industry…
2006 marked a major milestone, with the Pharmaceutical Industry Action Agenda transformed from a Government-industry initiative into an…

Interview with George Varkanis, Managing Director, Celgene
As a biopharmaceutical company, how have the PBS reforms affected Celgene? Celgene looks at the PBS reforms more positively than negatively. As a…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here